The healthcare transparency regulations implemented during the first Trump administration represented a significant step toward empowering patients and increasing market competition. The intent was clear: give patients the ability to know what their healthcare will cost, just like any other purchase decision in their lives. However, the Patient Rights Advocate's (PRA) seventh Semi-Annual Hospital Price Transparency Report, released in November 2024, found that only 21.1% of the 2000 hospitals reviewed nationwide were fully compliant with the federal price transparency rules - despite the mandate being in effect since 2021. This marks a substantial decline from the 34.5% compliance reported by PRA in February 2024.
The Promise vs. The Reality
The transparency regulations required both providers and payers to publish machine-readable files containing their rates and reimbursement information. Hospitals must publish their chargemasters and procedure codes, while insurance companies must disclose their contracted rates with providers. In theory, this should create a harmonious system where patients can easily compare costs and make informed decisions.
In practice, it's far more complicated. Consider this real-world scenario: Two 55-year-old men in the same zip code need hip replacement surgery at the same hospital on the same day. Both have identical insurance coverage. The first patient's procedure costs $55,000, while the second patient - receiving what should be an identical service - faces a $90,000 bill simply because of different implant choices or billing variations.
Recent data further highlights the inconsistency:
- A December 2024 analysis by the Congressional Research Service and JAMA Network Open found that negotiated prices for the same procedure within a single hospital ranged from $14,306 to $56,695, depending on the insurer.
- In December 2023, Patient Rights Advocate (PRA) reported that within a single hospital, the price for the same procedure can vary more than tenfold when comparing insurance plan negotiated rates and the discounted cash price. Across different hospitals in the same state, prices for the same procedure can differ by more than 31 times.
- The Healthcare Accountability Report from the New York City Department of Health and Mental Hygiene released in March of 2025 pointed out that inpatient prices ranged from 256% to 520% of Medicare, a colonoscopy costs anywhere from $940 to $12,000, a moderate-intensity ER visit varies from $2,097 to $5,376, etc., etc.
This variability illustrates the core problem: transparency alone isn't enough when billing practices and claims payment processes lack standardization across providers and payers, limiting their practical value.
The Technology and Incentive Barriers
The challenges go beyond just good intentions. The current Electronic Data Interchange (EDI) transaction systems that facilitate communication between providers and payers are surrounded by systems that both parties find inadequate. While the Centers for Medicare and Medicaid Services (CMS) requires hospitals and insurers to post machine-readable files with price transparency data, concerns exist regarding the accuracy and completeness of that data. For example, the Government Accountability Office (GAO) notes that CMS has not assessed whether these files are "sufficiently complete and accurate" to meet program goals, even though incomplete or inaccurate data poses risks to CMS's objectives for hospital price transparency - reflecting minimal enforcement of data quality standards. Revenue cycle management systems are designed to maximize provider revenue by identifying payment trends and adjusting billing accordingly. Meanwhile, payers constantly adjust their claims payment systems to address provider billing patterns.
This creates a perpetual cycle where both parties are essentially gaming each other's systems, adding administrative burden and complexity that works against transparency goals.
Perhaps more significantly, not all providers and payers truly want full transparency. Many providers continue to enforce now-defunct contract clauses like most favored nation agreements and non-disclosure provisions, despite these being rendered unenforceable by transparency laws. Payers, meanwhile, are content to avoid compliance based on provider objections. Both parties can maintain these positions because the regulations have historically lacked meaningful enforcement mechanisms.
The Path Forward
Real progress requires addressing both the technical infrastructure and the incentive structure. Employers are beginning to favor fixed-price or predictable pricing contracts and are rewarding employees who choose transparent, cost-effective providers. Some benefit design changes are recognizing and rewarding lower-cost, high-quality providers.
Meaningful change will require simplifying the administrative process for both providers and patients. This includes streamlining billing so patients receive consolidated bills rather than multiple charges from different entities involved in their care, and ensuring that cost estimates actually match final bills.
The healthcare transparency movement will succeed when patients consistently receive the $500 bill they were quoted, not the $5,000 surprise that destroys trust in the system. Until then, the promise of healthcare consumerism remains unfulfilled, and patients continue to navigate a system where they're expected to make informed financial decisions with insufficient, unreliable information.
Roger Francoline is President at Oxbridge, bringing extensive experience in healthcare operations and regulatory compliance to the transparency challenge.